Optimal Candidates for the Switch from Glimepiride to Sitagliptin to Reduce Hypoglycemia in Patients with Type 2 Diabetes Mellitus
Open Access
- 1 January 2015
- journal article
- Published by Korean Endocrine Society in Endocrinology and Metabolism
- Vol. 30 (1) , 84-91
Abstract
Kim HM, et al. Endocrinol Metab. 2015 Mar;30(1):84-91. http://dx.doi.org/10.3803/EnM.2015.30.1.84Keywords
This publication has 33 references indexed in Scilit:
- Sitagliptin: a reviewExpert Opinion on Pharmacotherapy, 2011
- Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of TherapyDiabetes Care, 2009
- Sitagliptin, a DPP-4 inhibitor for the treatment of patients with type 2 diabetes: a review of recent clinical trialsCurrent Medical Research and Opinion, 2008
- β-Cell Failure in Diabetes and Preservation by Clinical TreatmentEndocrine Reviews, 2007
- The place of sulfonylureas in the therapy for type 2 diabetes mellitusMetabolism, 2006
- Glycemic Control Continues to Deteriorate After Sulfonylureas Are Added to Metformin Among Patients With Type 2 DiabetesDiabetes Care, 2005
- The National Glycohemoglobin Standardization Program: A five-year progress report2001
- Assessment of insulin sensitivity and beta-cell function from measurements in the fasting state and during an oral glucose tolerance testDiabetologia, 2000
- Inhibition of the activity of dipeptidyl-peptidase IV as a treatment for type 2 diabetes.Diabetes, 1998
- Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in manDiabetologia, 1985